Chinese Medical Sciences Journal ›› 2021, Vol. 36 ›› Issue (1): 57-65.doi: 10.24920/003737

• Review • Previous Articles     Next Articles

Research Progress in Targeted Therapy of Hepatocellular Carcinoma

Qiong Chen, Xuefeng Yang()   

  1. Department of Gastroenterology, the Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan Province 421002, China
  • Received:2020-03-06 Accepted:2020-05-11 Published:2021-03-31 Online:2021-04-14
  • Contact: Xuefeng Yang E-mail:yxf9988@126.com

Hepatocellular carcinoma (HCC) is one of the most common malignancies, and its treatment is limited. With the understanding of key genes and signaling pathways in the occurrence and development of HCC, targeted drugs with high selectivity and low toxicity have been developed continuously, bringing a variety of options for the treatment of advanced HCC. In this article, the research progress on representative drugs of targeted therapy and potential therapeutic targets for HCC are reviewed.

Key words: hepatocellular carcinoma, targeted therapy, genes, signaling pathway, drug

Funding: Funded by the Research Project 2017 of Health and Family Planning Commission of Hunan Province(A2017015)

Copyright © 2021 Chinese Academy of Medical Sciences.  京公安备110402430088  京ICP备06002729号-1  Powered by Magtech.

Supervised by National Health & Family Plan Commission of PRC

9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China

Tel: 86-10-65105897  Fax:86-10-65133074 

E-mail: cmsj@cams.cn  www.cmsj.cams.cn

Copyright © 2018 Chinese Academy of Medical Sciences

All right reserved.

京公安备110402430088  京ICP备06002729号-1